NHS approves £1.65m gene therapy for sickle cell disease, offering a potential cure. A milestone for patients, especially in ...

A groundbreaking sickle cell disease treatment has been approved for use in the UK's National Health Service (NHS). The treatment offers patients with severe forms of the condition hope for a ...

New gene therapies could transform sickle cell treatment forever. A future without pain crises or hospitalizations may finally be within reach.

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

The CDC reports about 100,000 people in the United States are affected by Sickle cell disease, and more than 90% are non-Black or African American. One local organization is aiming to shed light on ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Sickle cell disease impacts more than 100,000 people in the United States. It’s estimated that more than two million ...

This disturbing trend was discovered when the government officials investigated the blood samples of 6.96 lakh tribal people ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

Read about exa-cel being rolled out on the NHS, providing a 'functional cure' for some patients with severe sickle cell ...